Correction

Recently published articles about Correction

Correction

Correction. The Efficacy of Olanzapine/Samidorphan on Negative Symptoms

March 25, 2026

Correction

Correction. Long-Term Safety and Efficacy of Esmethadone in Patients With Major Depressive Disorder: Findings From a 12-Month Open-Label Study

May 2, 2025

Correction

Correction. Modern Psychedelic Microdosing Research on Mental Health: A Systematic Review

February 13, 2025

Correction

Correction. Ketamine vs Electroconvulsive Therapy in the Management of Treatment-Resistant Depression: Do We Need More Data?

February 11, 2025

Correction

Correction: Error in Author Degree

October 31, 2024

Correction

Correction. Reproductive Safety of Second-Generation Antipsychotics: Updated Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics

October 5, 2021

Adele C. Viguera, Marlene P. Freeman, Lina Góez-Mogollón, et al

Recent JCP Articles on Correction

Intrusive PTSD Symptoms and Elevated CRP in WTC Responders

Original Research

Intrusive PTSD Symptoms and Elevated CRP in WTC Responders

September 1, 2026

Emotional reactivity to trauma cues—not just PTSD severity—drives elevated CRP in WTC responders, thus a dual focus on PTSD and metabolic health may be the missing piece in inflammation...

Sarah B. Rutter, Abigail B. Collins, Marin Kautz, et al

Pharmacotherapies for Co-Occurring Stimulant Use Disorder and ADHD

Meta-Analysis

Pharmacotherapies for Co-Occurring Stimulant Use Disorder and ADHD

August 31, 2026

Stimulant-based pharmacotherapies, particularly higher-dose methylphenidate and mixed amphetamine salts, were associated with superior outcomes for both stimulant-use indicators and ADHD symptoms.

Henrique N. P. Oliva, Alejandra Pulido-Saavedra, Alisson M. Paredes Naveda, et al

Electroconvulsive Therapy and All-Cause, Nonsuicide, and Suicide Mortality

Clinical and Practical Psychopharmacology

Electroconvulsive Therapy and All-Cause, Nonsuicide, and Suicide Mortality

August 31, 2026

Evidence on the association of ECT with lower risk of short- and long-term all-cause mortality, nonsuicide mortality, and suicide mortality is reviewed.

Chittaranjan Andrade

Recent PCC Articles on Correction

Improved but Not Recovered: The Relapsing Course of Generalized Anxiety Disorder

news

Improved but Not Recovered: The Relapsing Course of Generalized Anxiety Disorder

August 28, 2026

GAD follows a chronic, relapsing course in which comorbidity reduces recovery odds and antidepressant discontinuation roughly triples relapse risk.

Safety Across Classic Psychedelics in GAD: What Three Investigational Programs Show So Far

news

Safety Across Classic Psychedelics in GAD: What Three Investigational Programs Show So Far

August 28, 2026

Early safety data from lysergide, psilocybin, and deuterated DMT GAD trials show predominantly mild-to-moderate, session-concentrated adverse events across all three programs.

Managing 7-hydroxymitragynine Withdrawal

Case Report

Managing 7-hydroxymitragynine Withdrawal

August 27, 2026

A 49-year-old man taking “7-OH” experienced signiﬁcant opioid withdrawal symptoms that resolved with high-dose buprenorphine-naloxone treatment.

Jacob T. Held, Francisco P. Varicat

Featured Correction Research

Obstetric Risk Associated with Stimulant vs Nonstimulant Treatment

Original Research

Obstetric Risk Associated with Stimulant vs Nonstimulant Treatment

August 26, 2026

Stimulant and nonstimulant use during pregnancy were both associated with increased risk for obstetric complications vs no medication.

Dara E. Babinski, Wen-Jan Tuan

ADHD Medication Safety in Pregnancy: Precise Estimates, Uncertain Causal Inference

Commentary

ADHD Medication Safety in Pregnancy: Precise Estimates, Uncertain Causal Inference

August 26, 2026

Comments on a recent study by Babinski and Tuan finding ADHD medication use predictive of adverse pregnancy outcomes.

Jacqueline M. Cohen

The Prescriber’s Guide to Oral Ketamine for Depression

Clinical and Practical Psychopharmacology

The Prescriber’s Guide to Oral Ketamine for Depression

August 26, 2026

Explains clinical contexts in which oral ketamine can be used and presents a detailed protocol for the use of this intervention.

Chittaranjan Andrade